Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | eukaryotic translation initiation factor 4H | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | eukaryotic translation initiation factor 4b:4h | eukaryotic translation initiation factor 4H | 248 aa | 217 aa | 26.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0035 | 0.0637 | 0.0916 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0034 | 0.0587 | 0.0845 |
Brugia malayi | RNA binding protein | 0.0163 | 0.5573 | 0.6406 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0035 | 0.0637 | 0.0916 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0058 | 0.1541 | 0.1772 |
Loa Loa (eye worm) | hypothetical protein | 0.0163 | 0.5573 | 0.6406 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0637 | 0.0732 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0035 | 0.0637 | 0.0916 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0035 | 0.0637 | 0.0916 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0035 | 0.0637 | 0.0916 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0035 | 0.0637 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0035 | 0.0637 | 0.0916 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0828 | 0.0952 |
Echinococcus multilocularis | Eukaryotic translation initiation factor 4H | 0.0163 | 0.5573 | 0.8018 |
Schistosoma mansoni | hypothetical protein | 0.0198 | 0.6951 | 1 |
Plasmodium vivax | SET domain protein, putative | 0.0035 | 0.0637 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0058 | 0.1541 | 0.1772 |
Schistosoma mansoni | eukaryotic translation initiation factor 4h | 0.0163 | 0.5573 | 0.8018 |
Brugia malayi | Pre-SET motif family protein | 0.0035 | 0.0637 | 0.0732 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.0828 | 0.1191 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0244 | 0.87 | 1 |
Schistosoma mansoni | eukaryotic translation initiation factor 4h | 0.0163 | 0.5573 | 0.8018 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0058 | 0.1541 | 0.1772 |
Schistosoma mansoni | hypothetical protein | 0.0198 | 0.6951 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0244 | 0.87 | 1 |
Echinococcus granulosus | Eukaryotic translation initiation factor 4H | 0.0163 | 0.5573 | 0.8018 |
Schistosoma mansoni | eukaryotic translation initiation factor 4h | 0.0163 | 0.5573 | 0.8018 |
Echinococcus granulosus | geminin | 0.0198 | 0.6951 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0035 | 0.0637 | 0.0916 |
Trichomonas vaginalis | set domain proteins, putative | 0.0277 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.1541 | 0.1772 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.004 | 0.0828 | 0.0952 |
Echinococcus multilocularis | geminin | 0.0198 | 0.6951 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 5.18 uM | PUBCHEM_BIOASSAY: SAR analysis for the identification of translation initiation inhibitors (eIF4H). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2012, AID2014, AID2028] | ChEMBL. | No reference |
IC50 (functional) | > 100 uM | PUBCHEM_BIOASSAY: SAR analysis for the identification of translation initiation inhibitors (PABP). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2012, AID2014, AID2030] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.